Clinical Trial Update: Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating volociximab in combination with dacarbazine in patients with metastatic melanoma not previously treated with chemotherapy has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Volociximab (volociximab)

Snippet

Sponsor: PDL BioPharma, Inc. | Conditions: Melanoma, Metastases | Phase 2 | Status: COMPLETED